Why Memorial Hermann invested in $17M+ round for data startup

A leader from Houston-based Memorial Hermann Health System told Becker’s it invested in an imaging data startup to better predict the way diseases evolve.

Advertisement

The health system joined New Hyde Park, N.Y.-based Northwell Health in investing in a $17.75 million funding round Feb. 18 that launched Avandra.

“As we think about transforming the way healthcare is accessed, experienced and delivered, we think there is a significant use case of the leveraging of data and analytics and digital health solutions, whether they’re AI-enabled or otherwise, into a number of applications,” Feby Abraham, PhD, executive vice president and chief strategy and innovations officer of Memorial Hermann, told Becker’s.

Avandra, which aims to create a network of imaging data for medical researchers, biopharma and AI companies, was co-founded by investment firm Aegis Ventures, which hosts a digital consortium of health systems including Memorial Hermann and Northwell. Aegis and SpringRock Ventures co-led the funding round.

“We believe imaging data is a critical component of developing better predictive mechanisms to understand disease early but also over time, to know longitudinally how it’s evolving,” Dr. Abraham said.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.